Major pathways of polymyxin-induced apoptosis in rat kidney proximal tubular cells

Mohammad A K Azad1, Jesmin Akter1, Kelly L Rogers2

  • 1Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia.

Insights

Polymyxin B triggers kidney cell death via both death receptor and mitochondrial pathways. Understanding these mechanisms is key to developing safer antibiotics and reducing nephrotoxicity.

Area of Science:

  • Cell Biology
  • Pharmacology
  • Toxicology

Background:

  • Polymyxins are critical antibiotics for multidrug-resistant Gram-negative infections.
  • Nephrotoxicity is a significant dose-limiting side effect of polymyxin therapy.
  • Identifying apoptosis pathways is essential for mitigating toxicity and developing safer alternatives.

Purpose of the Study:

  • To elucidate the primary apoptotic pathways induced by polymyxin B in rat kidney proximal tubular cells (NRK-52E).
  • To investigate the roles of the death receptor and mitochondrial pathways in polymyxin-induced nephrotoxicity.

Main Methods:

  • Cultured rat kidney proximal tubular cells (NRK-52E) were treated with varying concentrations of polymyxin B.
  • Assays were performed to measure caspase activation (caspase-3, -8, -9).
  • Expression of Fas Ligand (FasL), mitochondrial morphology, mitochondrial membrane potential (Δψm), and mitochondrial superoxide production were assessed.

Main Results:

  • Polymyxin B activated caspases-3, -8, and -9 in a concentration-dependent manner.
  • FasL expression and mitochondrial morphology changes occurred in a concentration- and time-dependent manner.
  • Polymyxin B treatment led to decreased mitochondrial membrane potential and increased mitochondrial superoxide production.

Conclusions:

  • This study demonstrates that polymyxin B induces apoptosis in renal tubular cells through both death receptor and mitochondrial pathways.
  • Findings provide crucial insights for ameliorating polymyxin-induced nephrotoxicity.
  • The results support the development of novel, safer polymyxin-like antibiotics against Gram-negative superbugs.